Adekunle Oluwatosin Adeluwoye

Adekunle Oluwatosin Adeluwoye has had a long and successful career in the medical and educational fields. Adekunle Oluwatosin began their career in 2011 as a Medical Laboratory Scientist at the University College Hospital in Ibadan. In 2012, they moved to Molly Diagnostic Centre, Molly Specialist Hospital, 6, American Quarters, Yidi, Idi-Ape Area, Ibadan, where they served as a Medical Laboratory Scientist and Head. In 2016, they joined Babcock University Teaching Hospital, Ibadan Annex, as a Medical Laboratory Scientist and Laboratory Manager. Adeluwoye also founded two companies in 2016: PreDiagn, an on-demand digital diagnostic platform for users' access to lab tests on-the-go, and 228 Innoventure Ltd, an IT-focused, business development and support innovation start-up company. In 2017, they began working as a Lecturer/Faculty at Lead City University in Ibadan, Nigeria. In 2020, they became Program Director of Pine Biotech's OmicsLogic Africa/UREKA project. Adeluwoye also served as Executive Director of Operations for Blood Drive Initiative (BDI) from 2010-2017.

Adekunle Oluwatosin Adeluwoye obtained a Bachelor of Medical Laboratory Science (BMLS) from Ambrose Alli University in 2009, majoring in Biomedical Sciences (MLS). Adekunle Oluwatosin then went on to obtain a Master's Degree in Biochemistry (Cancer Research and Molecular Biology) from the University of Ibadan in 2016. Additionally, Adeluwoye has obtained two certifications from Coursera: Epidemiology: The Basic Science of Public Health in March 2014, and Contraception: Choices, Culture and Consequences in October 2013.